Summers v. Boehringer Ingelheim Pharmaceuticals Inc et al
Filing
3
CONDITIONAL TRANSFER ORDER (CTO-4) transferring case to the USDC for the Southern District of Illinois to be included with MDL No. 2385, IN RE: PRADAXA (DABIGATRAN ETEXILATE) PRODUCTS LIABILITY LITIGATION. Signed by Jeffery N. Luthi, Clerk of the Panel. (vjt)
FILED
U.S. DISTRICT COURT
EASTERN DISTHICT ARKANSAS
UNITED STATES JUDICIAL PANEL
AUG 2 9 2012
MULTIDISTRICT LITIGATION
JAMES W. McCORM"'GKCLERK
By:
v_--r_ -
on
DEPCLERK
IN RE: PRADAXA (DABIGATRAN ETEXILATE)
PRODUCTS LIABILITY LITIGATION
FfL~DNo.2385
AUG 2 9 20f2
(SEE ATTACHED SCHEDULE)
ClERK US
SOUTHERN
DISTRICT COURT
S~~t~RJ~Toc::;:lliNOIS
0
EAST
0
CONDITIONAL TRANSFER ORDER (CTO -4)
ce
On August 8, 2012, the Paneltransferred 13 civil action(s) to the United States District Court for the
Southern District of Illinois for coordinated or consolidated pretrial proceedings pursuant to 28
U.S.C. §1407. See _F.Supp.2d_ (J.P.M.L. 2012). Since that time, 17 additional action(s) have been
transferred to the Southern District of Illinois. With the consent of that court, all such actions have
been assigned to the Honorable David R Herndon.
It appears that the action(s) on this conditional transfer order involve questions of fact that are
common to the actions previously transferred to the Southern District of Illinois and assigned to
Judge Herndon.
Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict
Liti"ation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the
Southern District of Illinois for the reasons stated in the order of August 8, 2012, and, with the
consent of that court, assigned to the Honorable David R Herndon.
This order does not become effective until it is filed in the Office of the Clerk of the United States
District Court for the Southern District of Illinois. The transmittal of this order to said Clerk shall be
stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the
Panel within this 7-day period, the stay will be continued until further order of the Panel.
FOR THE PANEL:
Inasmuch as no objection is
pending at this time, the
stay is lifted.
,~
Jeffery N. Liithi
Clerk of the Panel
Aug 29,2012
CLERK'S OFFICE
UNITED STATES
JUDICIAL PANEL ON
MULTIDISTRICT LITIGATION
SOUTHERN DISTRICT OF ILLINOIS
By
iT~~py
Deputy Clerk
Date
Og fd.$Dif.r
1
IN RE: PRADAXA (DABIGATRAN ETEXILATE}
PRODUCTS LIABILITY LITIGATION
MDLNo.2385
SCHEDULE CT0-4- TAG-ALONG ACTIONS
C.A.NO.
CASE CAPTION
ARKANSAS EASTERN
ARE
4
12-00507
Summers v. Boehringer lngelheim Pharmaceuticals
Inc et all1· t?b0?0 Dtutj)Cw
ARKANSAS WESTERN
ARW
2
12-02185
ARW
3
12-03108
ARW
4
12-04096
Dalton v. Boehringer, Ingelheim Pharmaceuticals, Inc. \1.·bl>O?io OlttfSCW
et al
Brooks v. Boehringer, Ingelheim Pharmaceuticals, Inc.ll·~00;1 ORH/SCW
et al
Langdon v. Boehringer, lngelheim Pharmaceuticals, ll·L!OO~& 0rtH ~CW
Inc. et al
I
LOUISIANA WESTERN
LAW
2
12-02125
Hay v. Boehringer Ingelheim Pharmaceuticals Inc et all"Z·bbO~CJ Ol~ISCw'
TENNESSEE EASTERN
TNE
3
12-00419
TNE
3
12-00420
Zydel v. Boehringer Ingelheim Pharmaceuticals, Inc. tZ.·IoCOl\() ~t\\lSCw
et al
Marino v. Boehringer Ingelheim Pharmaceuticals, Inc.\1·b00~\ O~H\SCW
et al
TENNESSEE WESTERN
TNW
1
\l·loQOql 0~\\lStW
12-01177
Lunsford v. Boehringer Ingelheim Pharmaceuticals,
Inc. et al
.
Kee v. Boehringer lngelheim Pharmaceuticals, Inc. et\1..·\oOO'HOvtHISCW
al
Runte v. Boehringer Ingelheim Pharmaceuticals, Inc.\1· b(X)~'1- ~R\\ SC vJ
et al
~err v. Boehringer Ingelheim Pharmaceuticals, Inc. et n·~ooo"l'? Dtt\\~CvJ
TEXAS EASTERN
TXE
6
12-00497
TXE
6
12-00498
TXE
9
12-00125
I
TEXAS NORTHERN
TXN
2
12-00166
TXN
4
12-00555
TXN
4
12-00557
Jordan v. Boehringer Ingelheim Pharmaceuticals, Inc. \1·bOO~b O'-HjSCW
et al
Landers v. Boehringer Ingelheim Pharmaceuticals, \1.·b()b~l \)l.\\ISCW
Inc. et al
~frry v. Boehringer Ingelheim Pharmaceuticals, Inc. et\1.:~004~ Cl2.\\(scvJ
TXN
6
12-00053
~tlfv. Boehringer Ingelheim Pharmaceuticals, Inc. etll·Wt¥\ Urt\-\l \Cw
TEXAS SOUTHERN
TXS
4
12-02381
TXS
4
12-02427
Cannon v. Boehringer Ingelheim Pharmaceuticals, Inc.n·~t> \)'tJ\\ScvJ
et al
~a~ford v. Boehringer Ingelheim Pharmaceuticals, Inc.\l·\;l)()S\ \)~\\\Stw'
TEXAS WESTERN
TXW
1
12-00715
TXW
1
12-00716
Whitehouse v. Boehringer Ingelheim Pharmaceuticals, \1 iQ£111. O~"lSCvJ
Inc. et al
~onti v. Boehringer Ingelheim Pharmaceuticals, Inc. et(l·bOOc?; D~\\
\srw
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?